---
figid: PMC6329466__PO.18.00183f1
figlink: pmc/articles/PMC6329466/figure/f1/
number: F1
caption: Neurotrophic-tropomyosin receptor tyrosine kinase (NTRK) receptor signaling
  pathway and inhibitors. The ligands nerve growth factor (NGF), brain-derived neurotrophic
  factor (BDNF), neurotrophin 3 (NT-3), and NT-4 bind to their receptors, namely NTRK1
  (tropomyosin receptor kinase A or TrkA), NTRK2 (tropomyosin receptor kinase B or
  TrkB), and NTRK3 (tropomyosin receptor kinase C or TrkC). These receptors are under
  the regulation of the co-receptor p75 neurotrophin receptor (p75NTR). The binding
  of the ligand to the receptor promotes to the dimerization of the receptor and its
  subsequent intracellular phosphorylation. Several signaling cascades are further
  activated—phospholipase Cγ (PLC-γ), mitogen-activated protein kinase (MAPK), and
  phosphoinositide-3-kinase (PI3K) —and are converging to protumorigenic cell processes,
  such as proliferation, survival invasion, or differentiation. The hyperactivation
  of the NTRK signaling pathway induced by NTRK alterations—fusions or point mutations—can
  be overcome by the use of NTRK antagonists (eg, ANA-12 and cyclotraxin B) or small-molecule
  tyrosine kinase inhibitors (eg, larotrectinib and entrectinib). For now, only small-molecule
  tyrosine kinase inhibitors are used in the clinic.
pmcid: PMC6329466
papertitle: 'Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies:
  Implications for NTRK-Targeted Therapeutics.'
reftext: Ryosuke Okamura, et al. JCO Precis Oncol. 2018;2:PO.18.00183.
pmc_ranked_result_index: '58330'
pathway_score: 0.9334515
filename: PO.18.00183f1.jpg
figtitle: Neurotrophic-tropomyosin receptor tyrosine kinase (NTRK) receptor signaling
  pathway and inhibitors
year: '2018'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6329466__PO.18.00183f1.html
  '@type': Dataset
  description: Neurotrophic-tropomyosin receptor tyrosine kinase (NTRK) receptor signaling
    pathway and inhibitors. The ligands nerve growth factor (NGF), brain-derived neurotrophic
    factor (BDNF), neurotrophin 3 (NT-3), and NT-4 bind to their receptors, namely
    NTRK1 (tropomyosin receptor kinase A or TrkA), NTRK2 (tropomyosin receptor kinase
    B or TrkB), and NTRK3 (tropomyosin receptor kinase C or TrkC). These receptors
    are under the regulation of the co-receptor p75 neurotrophin receptor (p75NTR).
    The binding of the ligand to the receptor promotes to the dimerization of the
    receptor and its subsequent intracellular phosphorylation. Several signaling cascades
    are further activated—phospholipase Cγ (PLC-γ), mitogen-activated protein kinase
    (MAPK), and phosphoinositide-3-kinase (PI3K) —and are converging to protumorigenic
    cell processes, such as proliferation, survival invasion, or differentiation.
    The hyperactivation of the NTRK signaling pathway induced by NTRK alterations—fusions
    or point mutations—can be overcome by the use of NTRK antagonists (eg, ANA-12
    and cyclotraxin B) or small-molecule tyrosine kinase inhibitors (eg, larotrectinib
    and entrectinib). For now, only small-molecule tyrosine kinase inhibitors are
    used in the clinic.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BDNF
  - NTF4
  - NGF
  - SORT1
  - NTRK1
  - NTRK2
  - NTRK3
  - SMN1
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - cyclotraxin B
  - tyrosine
genes:
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: NT-4/5
  symbol: NT-4/5
  source: hgnc_alias_symbol
  hgnc_symbol: NTF4
  entrez: '4909'
- word: NGF
  symbol: NGF
  source: hgnc_symbol
  hgnc_symbol: NGF
  entrez: '4803'
- word: NT-3
  symbol: NT3
  source: hgnc_alias_symbol
  hgnc_symbol: SORT1
  entrez: '6272'
- word: NT-3
  symbol: NT3
  source: hgnc_alias_symbol
  hgnc_symbol: SORT1
  entrez: '6272'
- word: NTRK1
  symbol: NTRK1
  source: hgnc_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: NTRK2
  symbol: NTRK2
  source: hgnc_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: NTRK3
  symbol: NTRK3
  source: hgnc_symbol
  hgnc_symbol: NTRK3
  entrez: '4916'
- word: NTRK
  symbol: NTRK
  source: bioentities_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: NTRK
  symbol: NTRK
  source: bioentities_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: NTRK
  symbol: NTRK
  source: bioentities_symbol
  hgnc_symbol: NTRK3
  entrez: '4916'
- word: Small
  symbol: SMA2
  source: hgnc_alias_symbol
  hgnc_symbol: SMN1
  entrez: '6606'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PLC-y,MAPK,andPI3K/AKTpathways
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: cyclotraxin B
  source: MESH
  identifier: C554840
- word: tyrosine
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC6329466__F1
redirect_from: /figures/PMC6329466__F1
figtype: Figure
---
